Dr Charles G Petrunin Ii, MD in Salem, OR - Medicare Hematology/oncology

Dr Charles G Petrunin Ii, MD is a medicare enrolled "Internal Medicine - Hematology & Oncology" physician in Salem, Oregon. He went to University Of Nevada School Of Medicine and graduated in 1996 and has 28 years of diverse experience with area of expertise as Hematology/oncology. He is a member of the group practice Oregon Oncology Specialists Llp and his current practice location is 875 Oak St Se, Suite 4030, Salem, Oregon. You can reach out to his office (for appointments etc.) via phone at (503) 561-6444.

Dr Charles G Petrunin Ii is licensed to practice in Oregon (license number MD21956) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1881788099.

Contact Information

	Dr Charles G Petrunin Ii, MD
	875 Oak St Se, Suite 4030, Salem, OR 97301-3975
	(503) 561-6444
	(503) 561-6440

Physician's Profile

Full Name	Dr Charles G Petrunin Ii
Gender	Male
Speciality	Hematology/oncology
Experience	28 Years
Location	875 Oak St Se, Salem, Oregon
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr Charles G Petrunin Ii attended and graduated from University Of Nevada School Of Medicine in 1996

NPI Data:

NPI Number: 1881788099
Provider Enumeration Date: 10/03/2006
Last Update Date: 07/09/2007

Medicare PECOS Information:

PECOS PAC ID: 2466553581
Enrollment ID: I20070719000415

Medical Identifiers

Medical identifiers for Dr Charles G Petrunin Ii such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1881788099	NPI	-	NPPES
MD21956	Other	OR	OREGON LICENSE
229284	Medicaid	OR

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RH0003X	Internal Medicine - Hematology & Oncology	MD21956 (Oregon)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Salem Hospital	Salem, OR	Hospital
West Valley Hospital	Dallas, OR	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Oregon Oncology Specialists Llp	3971576240	38

News Archive

TNF inhibitors best cardiac option for psoriasis patients

Use of tumor necrosis factor inhibitors is associated with a significantly reduced risk for myocardial infarction in psoriasis patients compared with use of other medications, report researchers.

HSS, UCSF and Mayo Clinic to validate new MRI techniques, biomarkers for osteoarthritis treatment

In recent years, researchers have been frustrated because there are no tools to identify early stages of osteoarthritis and thus no good way to test therapies for preventing or slowing the disease. Now, three institutions have been awarded $1 million from the Arthritis Foundation to validate the use of new MRI (magnetic resonance imaging) techniques and newly identified biomarkers to solve this vexing problem.

PDL BioPharma purchases portion of royalties on expected sales of AcelRx's Zalviso

PDL BioPharma, Inc. announced today that it has acquired a portion of the royalties on expected sales of AcelRx Pharmaceuticals Inc.'s Zalviso (sufentanil sublingual tablet system) in the European Union, Switzerland and Australia by its commercial partner, Grunenthal.

Multimodality therapy critical for treating more aggressive prostate cancers

Men with high-risk prostate cancer with at least one additional aggressive feature have the best outcomes when treated with multiple healthcare disciplines, known as multimodality care, according to a UCLA study led by Dr. Amar Kishan, assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA and a researcher at the UCLA Jonsson Comprehensive Cancer Center.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Charles G Petrunin Ii allows following entities to bill medicare on his behalf.

Entity Name	Oregon Oncology Specialists Llp
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1013953025 PECOS PAC ID: 3971576240 Enrollment ID: O20040816000322

News Archive

TNF inhibitors best cardiac option for psoriasis patients

Use of tumor necrosis factor inhibitors is associated with a significantly reduced risk for myocardial infarction in psoriasis patients compared with use of other medications, report researchers.

HSS, UCSF and Mayo Clinic to validate new MRI techniques, biomarkers for osteoarthritis treatment

PDL BioPharma purchases portion of royalties on expected sales of AcelRx's Zalviso

Multimodality therapy critical for treating more aggressive prostate cancers

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Charles G Petrunin Ii is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr Charles G Petrunin Ii, MD 875 Oak St Se, Suite 4030, Salem, OR 97301-3975 Ph: (503) 561-6444	Dr Charles G Petrunin Ii, MD 875 Oak St Se, Suite 4030, Salem, OR 97301-3975 Ph: (503) 561-6444

News Archive

TNF inhibitors best cardiac option for psoriasis patients

Use of tumor necrosis factor inhibitors is associated with a significantly reduced risk for myocardial infarction in psoriasis patients compared with use of other medications, report researchers.

HSS, UCSF and Mayo Clinic to validate new MRI techniques, biomarkers for osteoarthritis treatment

PDL BioPharma purchases portion of royalties on expected sales of AcelRx's Zalviso

Multimodality therapy critical for treating more aggressive prostate cancers

Internal Medicine Doctors in Salem, OR

Dr. Andrew P. Hope, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se, Suite 4000, Salem, OR 97301 Phone: 503-364-0189 Fax: 503-364-9288
Brett W Mikeska, M D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se Ste 5070, Salem, OR 97301 Phone: 503-561-8565 Fax: 503-561-8560
Dr. Aneet Jyot Deo, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se Ste 5070, Salem, OR 97301 Phone: 503-561-8565 Fax: 503-561-8560
Joseph J Thaler, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5050 Skyline Village Loop S, Salem, OR 97306 Phone: 503-391-1110 Fax: 503-370-4237
Dr. Krystyna Antonina Pekalska, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 2400 Lancaster Dr Ne, Salem, OR 97305 Phone: 503-361-5400
Dr. Falguny I Bhavan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 875 Oak St Se, Ste 3010, Salem, OR 97301 Phone: 503-399-7520 Fax: 503-362-7344
Dr. Douglas Michael Carney, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 960 Liberty St Se Ste 140, Salem, OR 97302 Phone: 503-540-0304 Fax: 503-540-0305

Dr Charles G Petrunin Ii, MD - Medicare Hematology/oncology in Salem, OR

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

TNF inhibitors best cardiac option for psoriasis patients

HSS, UCSF and Mayo Clinic to validate new MRI techniques, biomarkers for osteoarthritis treatment

PDL BioPharma purchases portion of royalties on expected sales of AcelRx's Zalviso

Multimodality therapy critical for treating more aggressive prostate cancers

Medicare Reassignments

TNF inhibitors best cardiac option for psoriasis patients

HSS, UCSF and Mayo Clinic to validate new MRI techniques, biomarkers for osteoarthritis treatment

PDL BioPharma purchases portion of royalties on expected sales of AcelRx's Zalviso

Multimodality therapy critical for treating more aggressive prostate cancers

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

TNF inhibitors best cardiac option for psoriasis patients

HSS, UCSF and Mayo Clinic to validate new MRI techniques, biomarkers for osteoarthritis treatment

PDL BioPharma purchases portion of royalties on expected sales of AcelRx's Zalviso

Multimodality therapy critical for treating more aggressive prostate cancers

Internal Medicine Doctors in Salem, OR